About this Journal Submit a Manuscript Table of Contents
Advances in Pharmacological Sciences
Volume 2012 (2012), Article ID 465634, 7 pages
http://dx.doi.org/10.1155/2012/465634
Research Article

Biomarkers of Oxidative Stress and Personalized Treatment of Pulmonary Tuberculosis: Emerging Role of Gamma-Glutamyltransferase

1Faculty of Health Sciences, Anti-Tuberculosis Centre, National Laboratory of Public Health, Marien Ngouabi University, Brazzaville, Democratic Republic of Congo
2Faculty of Health Sciences, Walter Sisulu University, Private Bag X1, Eastern Cape, Mthatha 5117, South Africa

Received 14 December 2011; Accepted 4 February 2012

Academic Editor: Abdelwahab Omri

Copyright © 2012 Etienne Mokondjimobe et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. Balagopal, S. D. de Ferranti, S. Cook et al., “Nontraditional risk factors and biomarkers for cardiovascular disease: mechanistic, research, and clinical considerations for youth: a scientific statement from the american heart association,” Circulation, vol. 123, no. 23, pp. 2749–2769, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. D. A. Taha and A.-J. Thanoon, “Antioxidant status, C-reactive protein and iron status in patients with pulmonary tuberculosis,” Sultan Qaboos University Medical Sciences Journal, vol. 10, pp. 361–369, 2010.
  3. M. L. Put, A. J. Theron, H. Fickl, C. E. J. van Rensburg, S. Pendel, and R. Anderson, “Influence of antimicrobial chemotherapy and smoking status on the plasma concentrations of vitamin C, vitamin E, β-carotene, acute phase reactants, iron and lipid peroxides in patients with pulmonary tuberculosis,” International Journal of Tuberculosis and Lung Disease, vol. 2, no. 7, pp. 590–596, 1998. View at Scopus
  4. C. I. A. Jack, M. J. Jackson, and C. R. K. Hind, “Circulating markers of free radical activity in patients with pulmonary tuberculosis,” Tubercle and Lung Disease, vol. 75, no. 2, pp. 132–137, 1994. View at Publisher · View at Google Scholar · View at Scopus
  5. K. Yasuda, A. Sato, K. Chida et al., “Pulmonary tuberculosis with chemotherapy related liver dysfunction,” Kekkaku, vol. 65, no. 6, pp. 407–413, 1990. View at Scopus
  6. T. F. Brewer and S. J. Heymann, “To control and beyond: moving towards eliminating the global tuberculosis threat,” Journal of Epidemiology and Community Health, vol. 58, no. 10, pp. 822–825, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. A Tostmann, M. J. Boeree, R. E. Aanoutse, and R. Kedhuijzen, “Anti tuberculosis drug-induced hepatotoxicity: concise up-to-review,” Journal of Gastroenterology and Hepatology, vol. 23, pp. 192–202, 2008.
  8. E. J. Forget and D. Menzies, “Adverse reactions to first-time antituberculosis drugs,” Expert Opinion on Drug Safety, vol. 5, no. 2, pp. 231–249, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. Z. Hussain, P. Kar, and S. A. Husain, “Antituberculosis drug-induced hepatitis: risk factors, prevention and management,” Indian Journal of Experimental Biology, vol. 41, no. 11, pp. 1226–1232, 2003. View at Scopus
  10. T. R. Frieden, T. R. Sterling, S. S. Munsiff, C. J. Watt, and C. Dye, “Tuberculosis,” The Lancet, vol. 362, no. 9387, pp. 887–899, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. R. A. M. Breen, R. F. Miller, T. Gorsuch et al., “Adverse events and treatment interruption in tuberculosis patients with and without HIV co-infection,” Thorax, vol. 61, no. 9, pp. 791–794, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. K Krishnaswamy, C. E. Prasad, and K. J. Muthy, “Hepatic dysfunction in under nourished patients receiving isoniazid and rijampia,” Tropical and Geographical Medicine, vol. 43, pp. 156–160, 1991.
  13. J. S. Lim, J. H. Yang, B. Y. Chun, S. Kam, D. R. Jacobs Jr., and D. H. Lee, “Is serum γ-glutamyltransferase inversely associated with serum antioxidants as a marker of oxidative stress?” Free Radical Biology and Medicine, vol. 37, no. 7, pp. 1018–1023, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Bo, R. Gambino, M. Durazzo et al., “Associations between γ-glutamyl transferase, metabolic abnormalities and inflammation in healthy subjects from a population-based cohort: a possible implication for oxidative stress,” World Journal of Gastroenterology, vol. 11, no. 45, pp. 7109–7117, 2005. View at Scopus
  15. J. Yamada, H. Tomiyama, M. Yambe et al., “Elevated serum levels of alanine aminotransferase and gamma glutamyltransferase are markers of inflammation and oxidative stress independent of the metabolic syndrome,” Atherosclerosis, vol. 189, no. 1, pp. 198–205, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. World Health Organisation Global Tuberculosis Programme, Treatment of Tuberculosis: Guidelines for National Programmes, WHO/CDS/TUBERCULOS, World Health Organization, Geneva, Switzerland, 3rd edition, 2003.
  17. P. V. Kishore, S. Palaian, O. Pradir, and P. R. Shankar, “Pattern of adverse drug reactions experienced by tuberculosis patients in tertiary care teaching hospital in Western Nepal,” Pakistan Journal of Pharmaceutical Sciences, vol. 21, pp. 51–56, 2008.
  18. V. K. Dhingra, S. Rajpal, N. Aggarwal, J. K. Aggarwal, K. Shadab, and S. K. Jain, “Adverse drug reactions observed during DOTS,” Journal of Communicable Diseases, vol. 36, no. 4, pp. 251–259, 2004. View at Scopus
  19. M. F. Alexeyev, “Is there more to aging than mitochondrial DNA and reactive oxygen species?” FEBS Journal, vol. 276, no. 20, pp. 5768–5787, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. K. Kaur, J. Kishan, G. K. Bedi, and R. S. Ahi, “Oxidants stress and antioxidants in pulmonary tuberculosis,” Chest, vol. 128, p. 3975, 2005.
  21. Y. N. Reddy, S. V. Murthy, D. R. Krishna, and M. C. Prabhakar, “Role of free radicals and antioxidants in tuberculosis patients,” Indian Journal of Tuberculosis, vol. 51, pp. 213–218, 2004.
  22. T. Madebo, B. Lindtjørn, P. Aukrust, and R. K. Berge, “Circulating antioxidants and lipid peroxidation products in untreated tuberculosis patients in Ethiopia,” The American Journal of Clinical Nutrition, vol. 78, no. 1, pp. 117–122, 2003. View at Scopus
  23. A. Walubo, P. J. Smith, and P. I. Folb, “Oxidative stress during antituberculosis therapy in young and elderly patients,” Biomedical and Environmental Sciences, vol. 8, pp. 106–113, 1995.
  24. A. Agarwal, R. Prasad, and A. Jain, “Effect of green tea extract (catechins) in reducing oxidative stress seen in patients of pulmonary tuberculosis on DOTS Cat I regimen,” Phytomedicine, vol. 17, no. 1, pp. 23–27, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. E. Sevedrezazadeh, A. Ostradrahini, S. Mahboob, Y. Assadi, J. Ghaemmagami, and M. Poumogaddam, “Effect of vitamin E and selenium supplementation on oxidative stress status in pulmonary tuberculosis patients,” Respirology, vol. 13, pp. 294–298, 2008.